CORD-19:0036b28fddf7e93da0970303672934ea2f9944e7 / 82497-82648 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/0036b28fddf7e93da0970303672934ea2f9944e7","sourcedb":"CORD-19","sourceid":"0036b28fddf7e93da0970303672934ea2f9944e7","text":"Blood glucose curves from a recent prospective placebo-controlled clinical trial were evaluated for GV 1, 3, 6, 10 and 16 weeks after starting therapy.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T624","span":{"begin":0,"end":151},"obj":"Sentence"},{"id":"T35824","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T624","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T35824","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T157","span":{"begin":0,"end":5},"obj":"Body_part"}],"attributes":[{"id":"A157","pred":"uberon_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"subj":"T157","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#c5ec93","default":true},{"id":"CORD-19-PD-UBERON","color":"#ec93df"}]}]}}